Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40006193
Localisation
Netherlands
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
23/03/2023
Statut
Classification
1.5°C
Année cible
2030
Statut
Targets set
Classification
1.5°C
Année cible
2050
Overall Net-Zero Target QIAGEN N.V. commits to reach net-zero greenhouse gas emissions across the value chain by 2050 from a 2020 base year. Near-Term Targets QIAGEN N.V. commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2020 base year.* QIAGEN N.V. also commits to reduce absolute scope 3 GHG emissions from business travel, use of sold products and end-of-life treatment of sold products 25% within the same timeframe. QIAGEN N.V. further commits that 67% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution, will have science-based targets by 2027. *The target boundary includes land-related emissions and removals from bioenergy feedstocks. Long-Term Targets QIAGEN N.V. commits to reduce absolute scope 1, 2 and 3 GHG emissions 90% by 2050 from a 2020 base year.*
Statut
Targets setAnnée cible
2050
Statut
BA1.5 memberDate d'engagement
28/10/2021
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
NL0000240000
LEI
54930036WK3GMCN17Z57
Source : Science Based Targets initiative | Données publiques